RDG
READ-GENE NEWCONNECT LISTED

Shareholders

as of August 12, 2026 · source: notifications under Art. 69 of the Offering Act · 3 entities above 5% of votes

FREE FLOAT
19.84%
—
LARGEST STAKE
67.06%
GEN-PAT-MED Sp. z o.o.
TOP 3 CONCENTRATION
80.16%
3 entities above 5% of votes
LATEST CHANGE
—
no notification history

Ownership structure

stakes per latest notifications
SHAREHOLDERS ≥5% OF VOTES 80.16% FREE FLOAT 19.84%
GEN-PAT-MED Sp. z o.o. 67.06%
7,905,875 shares NOTIFICATION: Aug 12, 2026
Jan Lubiński 7.16%
843,856 shares NOTIFICATION: Aug 12, 2026
Adamed Pharma S.A. 5.94%
700,000 shares NOTIFICATION: Aug 12, 2026
Other 19.84%
— composition undisclosed

Announcement history

crossings above/below the 5% / 10% / 20% thresholds

No notification history recorded for this company.

History is built from art. 69 notifications — we have not recorded any yet.

Capital and votes

Number of shares
—
ISIN
PLRADGN00014
Sector
Biotechnologia
Market
NEWCONNECT
Country
PL
Listing date
May 17, 2026

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.

The share count behind every percentage comes from the newest (by as-of date) periodic report or art. 69 notification — not from the company's GPW/NewConnect profile.